RE:Encouraging Seems exciting. I would generally think of this as the expansion of the SORT1 technology that would come after validation of TH1902 in the present trial. After all if they have nothing coming out of this trial it's much harder to get the investment in follow on molecules. Having said that, in the scheme of things, it's a pretty small investment in one scientist and bench fees. So again it looks like they believe that the validation is coming (maybe).